Advanced Biomed Inc. Common Stock (ADVB) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 295 | 466 | 0 | 2.08K | 0 | 680 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -294 | -466 | 0 | -2.08K | 0 | -680 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | 31.46% | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 16.14K | 12.31K | 523.91K | 37.17K | 762.74K | 7.98K | 520.03K | 704.61K | 745.41K | 651.3K | 440.25K | 1.02M | 790.23K | 1.08M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 276.61K | 6.31K | 260.6K | 29.59K | 438.77K | 1.41K | 311.03K | 177.01K | 404.74K | 435.9K | 244.13K | 498.46K | 553.42K | 378.5K |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 7.69K | 6K | 235.99K | 7.58K | 250.46K | 6.57K | 181.7K | 209.11K | 313.51K | 188.39K | 169.19K | 488.17K | 208.17K | 574.29K |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | -268.16K | 0 | 27.32K | 0 | 73.51K | 0 | 27.29K | 318.49K | 27.16K | 27.01K | 26.93K | 32.53K | 28.64K | 129.74K |
| Operating Income | -16.43K | -12.78K | -523.91K | -39.26K | -762.74K | -8.66K | -520.03K | -704.61K | -745.41K | -651.3K | -440.25K | -1.02M | -790.23K | -1.08M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 97.85% | -47.55% | -0.75% | 94.43% | -2.32% | 98.67% | -18.12% | 30.86% | 5.67% | - | - | 5.85% | - | - |
| EBITDA | -16.14K | -12.31K | -475.92K | -37.17K | -528.77K | -7.98K | -417.81K | -386.12K | -662.4K | -577.94K | -350.94K | -852.18K | -758.87K | -968.14K |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 96.95% | -54.28% | -13.91% | 90.37% | 20.17% | 98.62% | -19.06% | 54.69% | 12.71% | - | - | 11.98% | - | - |
| D&A (Non-Cash Add-back) | 295 | 466 | 47.99K | 2.08K | 233.97K | 680 | 102.22K | 318.49K | 83.02K | 73.37K | 89.31K | 166.99K | 31.36K | 114.38K |
| EBIT | -16.43K | -12.78K | -523.91K | -39.26K | -762.74K | -8.66K | -520.03K | -704.61K | -745.41K | -651.3K | -440.25K | -1.02M | -790.23K | -1.08M |
| Net Interest Income | -4 | 297 | 448 | 308 | 0 | 475 | 10 | 33.41K | 104 | 19.97K | 14 | 21.28K | -545 | -58 |
| Interest Income | 0 | 297 | 448 | 308 | 0 | 475 | 10 | 33.41K | 104 | 19.97K | 14 | 21.28K | 0 | 0 |
| Interest Expense | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 976 | 238.37K | 137.01K | 16.54K | -621.13K | -9.26K | 254.45K | -104.77K | -310.82K | 505.96K | -331.07K | -661.41K | 272.13K | -1.62M |
| Pretax Income | -15.46K | 225.59K | -386.9K | -22.71K | -1.38M | -17.92K | -265.58K | -809.39K | -1.06M | -145.34K | -771.32K | -1.68M | -518.11K | -2.7M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -15.46K | 220.95K | -386.9K | -22.71K | -1.38M | -28.07K | -265.58K | -809.39K | -1.06M | -145.34K | -771.32K | -1.68M | -518.11K | -2.7M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 98.88% | 887.02% | -45.68% | 97.19% | -31.02% | 80.68% | 65.57% | 51.84% | -103.86% | - | - | 37.73% | - | - |
| Net Income (Continuing) | -15.46K | 225.59K | -386.9K | -22.71K | -1.38M | -17.92K | -265.58K | -809.39K | -1.06M | -145.34K | -771.32K | -1.68M | -518.11K | -2.7M |
| Discontinued Operations | 0 | -4.65K | 0 | 0 | 0 | -10.15K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.01 | 0.31 | -0.02 | -0.02 | -0.07 | -0.04 | -0.01 | -0.04 | -0.05 | -0.01 | -0.04 | 0.00 | 0.00 | 0.00 |
| EPS Growth % | 82.86% | 838.1% | -62.6% | 43.44% | -43.44% | - | 65.45% | - | - | - | - | - | - | - |
| EPS (Basic) | -0.01 | 0.31 | -0.02 | -0.02 | -0.07 | -0.04 | -0.01 | -0.04 | -0.05 | -0.01 | -0.04 | 0.00 | 0.00 | 0.00 |
| Diluted Shares Outstanding | 1.28M | 21.64M | 21.64M | 1.08M | 20.48M | 21.64M | 21.64M | 1M | 125M | 125M | 125M | 0 | 0 | 0 |
| Basic Shares Outstanding | 1.28M | 21.64M | 21.64M | 1.08M | 20.48M | 21.64M | 21.64M | 1M | 21.64M | 21.64M | 125M | 0 | 0 | 0 |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - |